Neutrophil Activation and Modulation

Klebanoff S. J. Clark R. A. , 1978. The neutrophil: Function and clinical disorders. Ed. Elsevier, Amsterdam.

Marasco W. A. Phan S. A. Krutzsch H. , 1984. Purification and identification of formylmethyonil-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli J. Biol. Che. 259, 5430–5439.

Fernandez H. N. Henson P. M. Otani A. Hugli T. E. , 1978. Chemotactic response to human C3a and C5a anaphylotoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J. Immunol. 120, 109–115.

Moser R. Schleiffenbaum B. Groscurth P. Ferh J. , 1989. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelia neutrophil passage. J. Clin. Invest. 83, 444–455.

Gamble J. R. Harlan J. M. Klebanoff S. J. Lopez A. F. Vadas M. A. , 1985. Stimulation of the adherence of neutrophils to umbelical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. USA. 82, 8667–8671.

Schleimer R. P. Rutledge B. K. , 1986. Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. J. Immunol. 136, 649–654.

Lehrer R. I. Gauz T. Selsted M. E. Babior B. M. Curnutte J. T. , 1988. Neutrophils and host defence. Ann. Int. Med. 109, 127–142.

Weiss S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365–376.

Sandborg R. R. Smolen J. E. , 1988. Biology of disease. Early biochemical events in leukocyte activation. Lab. Invest. 59, 300–220.

Korchak H. M. Rutheford L. E. Weissmann G. , 1984 Stimulus response coupling in the human neutrophil. J. Biol. Chem. 259, 4070–4075.

Berridge M. J. 1984. Inositolo triphosphate and diacylglycerol as second messengers. Biochem. J. 220, 343–360.

Spagnuolo P. J. Ellner J. J. Assid A. Dunn M. J. , 1980. TxA2 modulates augmented polymorphonuclear leukocyte adhesiveness. J. Clin. Invest. 66, 406–412.

Palmer R. M. J. Yeats D. A. , 1981. Leukotriene B: A potent chemotactic agent and stimulus for lysosomal enzyme secretion from human neutrophils. Br. J. Pharmacol. 73, 260–265.

Ingraham L. M. Coates T. D. Allen J. M. Higgins C. P. Baehner R. L. Boxer L. A. , 1982. Metabolic, membrane and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood 59, 1259–1265.

Boxer L. A. Allen J. M. Bahner R. L. , 1980. Diminished polymorphonuclear adherence. Function dependent on release of cyclic AMP by endothelial cells after stimulation of β-receptors by epinephrine. J. Clin. Invest. 66, 268–274.

Ignarro L. J. Lint T. F. George W. J. , 1974. Hormonal control of lysosomal enzyme release from human neutrophils. J. Exp. Med. 139, 1395–1414.

Weisdorf D. J. Jacob H. S. , 1987. β-adrenergic blockade: Augmentation of neutrophil-mediated inflammation. J. Lab. Clin. Med. 109, 120–126.

Melmon K. L. Rocklin R. E. Rosenkranz R. P. , 1981. Autacoids as modulators of the inflammatory and immune response. Am. J. Med. 71, 100–106.

Landos C. Wolff J. Cooper D. M. F. , 1981. Adenosine as a regulator of adenylate cyclase. In Receptor and Recognition, Series B, Vol. 12, Purinergic Receptors, Burnstock G. , ed. Chapman and Hall, London. p. 287.

Cronstein B. N. Kramer S. B. Weissmann G. Hirschhorn R. , 1983. Adenosine: A physiologic modulator of superoxide anion generation by human neutrophils. J. Exp. Med. 158, 1160–1177.

Pasini F. Laghi Capecchi P. L. Orrico A. Ceccatelli L. Di Perri T. , 1985. Adenosine inhibits polymorphonuclear leukocyte in vitro activation: A possible role as an endogenous calcium entry blocker. J. Immunopharmacol. 7, 203–215.

Cronstein B. N. Kramer S. B. Weissmann G. Hirshhorn R. , 1984. Adenosine deaminase is not required for the generation of superoxide anion. Clin. Immunol. Immunopathol. 30, 495–522.